Mr. Daizong Li brings over 30 years of academic and industry experience in cancer research, neuroscience, and molecular biology product development. Prior to joining MedAbome, he co-founded and served as CEO of two antibody-focused biotech startups, and was a scientific consultant at Washington University in St. Louis, advising on the discovery and development of therapeutic antibodies. He previously served as Director of the Molecular Biology Group at Clontech Laboratories (now Takara Bio USA), where he led the development of a wide range of reagents and kits for molecular and cellular biology research. Earlier in his career, he was a visiting scholar at both Harvard Medical School and UCSF. 

Mr. Li holds a B.S. degree from the University of Science and Technology of China and a M.S. degree in Molecular Biology and Molecular Oncology from Shanghai Second Medical School.